Abstract Submission Information

1. The person submitting the abstract will automatically be the Presenting Author and the corresponding author.
   • If the presenting author is an APSR member, please provide the same email address from which you received your membership number information.
2. The presenting authors must be one of the co-authors of the submitted abstract.
3. There is no limit on how many abstracts can be submitted by a single presenting author.
4. Abstracts must be submitted electronically through the online abstract submission platform.
5. The presenting authors must ensure that all authors have given their consent to be listed as co-authors on the submitted abstract.
   • Authorship and author order should be agreed upon by all authors.
6. The presenting authors are required to complete a Declaration of Conflict of Interest. Abstracts supported in whole or in part by tobacco or tobacco-related industry will not be accepted.
7. The presenting authors must specify their own sponsoring entity in addition to that of all co-authors.
8. The presenting author must ensure that the contents of the abstract do not infringe the copyright and any other rights of any third party.
9. The presenting authors must choose one category for each abstract from the following:
   1. Clinical Respiratory Medicine
   2. Cell and Molecular Biology
   3. Clinical Allergy and Immunology
   4. Environmental & Occupational Health and Epidemiology
   5. Respiratory Infections (non-tuberculous)
   6. Tuberculosis
   7. COPD
   8. Lung Cancer
   9. Asthma
   10. Respiratory Neurobiology and Sleep
   11. Critical Care Medicine
   12. Bronchoscopy and Interventional Techniques
   13. Paediatric Lung Disease
   14. Respiratory Structure and Function
   15. Pulmonary Circulation
   16. Interstitial Lung Disease
10. The presenting authors may request their preferred presentation method as oral, poster, or either. The Scientific Programme Committee will consider your request but will make the final decision on the presentation format.
11. Submission of closely related abstracts from the same group is discouraged.
12. Splitting of a body of work into multiple abstracts is discouraged and consolidation into one abstract is preferred.
13. Submission and presentation of abstracts are subject to the principle of no duplication or plagiarism in publications. Breaching of such rules will lead to rejection of submission or presentation at the Congress without refund of registration fee. All decisions are final with the Central and Local Congress Committee.
14. If identical abstracts are found to be submitted, only the abstract on the latest date of the submission will be considered for evaluation without prior notice.
15. The presenting authors are responsible for the accuracy of all contents of the abstract.
16. By submitting the abstract, the presenting authors confirm that the presented study meets the ethical guidelines for research and publication, including the legal requirements of the country in which the study was conducted.

1. Submissions of encore abstracts are NOT allowed. If encore abstracts are found to be submitted, the abstracts shall be rejected without prior notice.
2. The presenting authors must declare during the submission that the material in the presentation is original and that it will not be published or presented elsewhere before the APSR 2026 Congress.
3. Authors can submit the same abstracts or findings to other events but MUST WITHDRAW the abstracts if they are presented and published before the APSR Congress.
4. Authors can submit findings which are published in the supplement of Respirology to other journals but are required to disclose the prior abstract publication to the journal they are submitting to. However, the following will be regarded as an encore abstract in the supplement of Respirology and the abstract will need to be withdrawn:
   An author submits the findings to the congress as an abstract, and simultaneously submits the same findings to Respirology/other journals as a full paper, which is then accepted by Respirology/other journals and published before the Congress.

1. Language: English ONLY
   Abstracts that contain non-English words/characters shall be rejected without prior notice.
2. Authors:
   • The abstract is limited to a maximum of 15 co-authors per abstract.
   • Authors' names should be provided in: ⇒ Example:
     (Correct) John Smith
     (Incorrect) John S. / J. Smith / JOHN SMITH
     • initial capital/lower case, NOT all capital/lower case.
     • full name, in 'Given name Family name' order.
   • Post-nominal/degrees are NOT required.
3. Affiliation
   • The 1^st author's affiliation should be listed first.
   • Department/Faculty/Division, Institution, City, Country/Region must be provided in each corresponding field.
   • Full name of the author's institution must be provided.
     ⇒ Example:
     (Correct) Asian Pacific Hospital
     (Incorrect) AP Hospital
   • If authors do not have fixed affiliations, provide the affiliation where the work was conducted and/or the patient was treated.
   • Job position/role (e.g. Registrar, Trainee, etc.) should not be included in affiliations.
4. Title:
   • The abstract title should be less than 25 words.
   • Capitalize the first letter of the title only (do not use all caps). *exception: unique words
     ⇒ Example:
     (Correct) The solution to air pollution
     (Incorrect) THE SOLUTION TO AIR POLLUTION
5. Abstract Structure:
   Abstracts that do not comply with the size requirement and structure may be rejected without prior notice.
   • The abstract body must be less than 300 words.
   • The following are excluded from the word count:
     • Title
     • Author / Affiliation information
     • Keywords in the "Keywords" field
     • Acknowledgements/Disclosure Statement
     • Figure/Table
     • Sub-headings
   • The abstract must have the following sub-headings depending on the abstract type:
     • Original Research: Background and Aims - Methods – Results – Conclusion
     • Case Report: Introduction - Case Report – Discussion
     • Trial in Progress(TiP) Abstract: Background – Methods  *See Trial in Progress (TiP) Abstract
   • Abbreviations must be defined in parentheses on the first mention in the text.
6. Keywords
   • ​​Keywords should be limited to THREE and provided in each corresponding field.
   • Abbreviations should be avoided in the keywords list.
7. References:
   References that don’t follow the required format will be removed without prior notice.
   • References are discouraged and should be limited to THREE.
   • References should be placed immediately after the statement in which they are mentioned, following this format:
   • Authors, Journal, Year, Volume, First and Last Pages
     • ➡Example: (Smith N et al, Respirology, 2024, 29, 951-961)
   • References are included in the word count limit for the abstract body.
8. Acknowledgements/Disclosure Statement:
   Any Acknowledgements or Disclosure Statement should be listed in each corresponding field if any.
9. A Case Report / A Series of Case Reports:
   • Abstract may describe a single case report or a series of associated cases.
   • A case report should describe only a single case and contain a description of the actual case, and a discussion of the novelty and importance of the specific case.
   • A case report must have the designated sub-headings. (See Format and Content - #5 Abstract Structure in the Abstract Submission Guideline)
10. Systematic Review and Meta-analysis:
    • Systematic reviews that include clear questions and scientific analysis such as meta-analysis CAN be submitted.
    • Systematic reviews and meta-analysis must have the same sub-headings as the Original Research. (See Format and Content - #5 Abstract Structure in the Abstract Submission Guideline)
11. Literature review
    A literature review abstract can NOT be submitted.
12. Trial in Progress (TiP) Abstract
    A TiP abstract CAN be submitted. See the section "Trial in Progress (TiP) Abstract"

The Inclusion of tables and figures is strongly DISCOURAGED. Authors are encouraged to describe the content of figures or tables in text form within the abstract, and to present figures and tables during the oral or poster presentation instead.

Nevertheless, if the inclusion of a figure or a table is deemed absolutely necessary for the proper understanding of the abstract, authors must comply with the following regulations.

1. Inclusion of tables and figures is discouraged and should be limited to a maximum of 1 figure or 1 table.
2. Author headshots/group shots are not appropriate and will not be published.
3. Any patient personal data/information and image in the figure/table must be de-identified. Failure to do so may result in rejection of the abstract or removal of the figure/table without prior notice.
4. If a table or figure is included, it must be cited in the abstract text.
5. Figures must be sharp, and all text must be legible.
6. Format: JPG, JPEG or PNG format ONLY (Extension should be .jpg / .jpeg /.png)
7. Recommended figure dimensions:
   • Minimum: 1,000 x 750 pixels
   • Maximum: 2,000 x 1,500 pixels
8. Maximum file size: 2 MB per figure
9. Filename: Alphanumeric characters ONLY
10. When including a table, it is recommended to save the table as an image before uploading it.

A Figure and table that do not comply with the requirements above and are considered inappropriate may be removed without prior notice.

Figures or tables that are unclear, including those with illegible text, may also be removed without prior notice.

Images that can identify patient

Author's shot

Author's group shot

Image that is excessively unclear

Table/graph/chart that contains excessively illegible